MetLife 2012 Annual Report Download - page 173

MetLife, Inc.
Notes to the Consolidated Financial Statements — (Continued)
Account Party/Borrower(s) Expiration Capacity
Letter of
Credit
Issuances Drawdowns Unused Commitments
(In millions)
MetLife, Inc. ............................................... August 2013 $ 300 $ 300 $ — $ —
Exeter Reassurance Company, Ltd., ............................
MetLife, Inc. & Missouri ....................................
Reinsurance, Inc. ......................................... June 2016 500 490 — 10
MetLife Reinsurance Company of ..............................
Vermont & MetLife, Inc. .................................... December 2020 (1) 350 350 — —
Exeter Reassurance Company, Ltd. ............................ December 2027 (1) 650 555 — 95
MetLife Reinsurance Company of ..............................
South Carolina & MetLife, Inc. ............................... June 2037 (2) 3,500 — 2,797 703
MetLife Reinsurance Company of ..............................
Vermont & MetLife, Inc. .................................... December 2037 (1) 2,896 1,825 — 1,071
MetLife Reinsurance Company of ..............................
Vermont & MetLife, Inc. .................................... September 2038 (1) 4,250 2,018 — 2,232
Total ................................................. $12,446 $5,538 $2,797 $4,111
(1) MetLife, Inc. is guarantor under this agreement.
(2) The drawdown on this facility is associated with a collateral financing arrangement described more fully in Note 13.
As a result of the offerings of certain senior notes (see “— Senior Notes — Other Issuances”) and common stock (see Note 16), the commitment
letter for a $5.0 billion senior credit facility, which MetLife, Inc. signed to partially finance the ALICO Acquisition, was terminated. During March 2010,
MetLife, Inc. paid $28 million in fees related to this senior credit facility, all of which were included in other expenses during the year ended
December 31, 2010.
13. Collateral Financing Arrangements
Associated with the Closed Block
In December 2007, MLIC reinsured a portion of its closed block liabilities to MRC, a wholly-owned subsidiary of MetLife, Inc. In connection with this
transaction, MRC issued, to investors placed by an unaffiliated financial institution, $2.5 billion in aggregate principal amount of 35-year surplus notes to
provide statutory reserve support for the assumed closed block liabilities. Interest on the surplus notes accrues at an annual rate of three-month LIBOR
plus 0.55%, payable quarterly. The ability of MRC to make interest and principal payments on the surplus notes is contingent upon South Carolina
regulatory approval.
Simultaneous with the issuance of the surplus notes, MetLife, Inc. entered into an agreement with the unaffiliated financial institution, under which
MetLife, Inc. is entitled to the interest paid by MRC on the surplus notes of three-month LIBOR plus 0.55% in exchange for the payment of three-month
LIBOR plus 1.12%, payable quarterly on such amount as adjusted, as described below. MetLife, Inc. may also be required to pledge collateral or make
payments to the unaffiliated financial institution related to any decline in the estimated fair value of the surplus notes. Any such payments would be
accounted for as a receivable and included in other assets on the Company’s consolidated balance sheets and would not reduce the principal amount
outstanding of the surplus notes. Such payments would, however, reduce the amount of interest payments due from MetLife, Inc. under the agreement.
Any payment received from the unaffiliated financial institution would reduce the receivable by an amount equal to such payment and would also
increase the amount of interest payments due from MetLife, Inc. under the agreement. In addition, the unaffiliated financial institution may be required to
pledge collateral to MetLife, Inc. related to any increase in the estimated fair value of the surplus notes. MetLife, Inc. may also be required to make a
payment to the unaffiliated financial institution in connection with any early termination of this agreement.
In June 2012 and December 2011, following regulatory approval, MRC repurchased and canceled $451 million and $650 million, respectively, in
aggregate principal amount of the surplus notes. Payments made by the Company in June 2012 and December 2011 associated with the partial
repurchases, which also included payments made to the unaffiliated financial institution, totaled $451 million and $650 million, respectively, exclusive of
accrued interest on the surplus notes. In connection with the partial repurchases, in June 2012 and December 2011, the amount of the receivable from
the unaffiliated financial institution decreased $59 million and $84 million, respectively.
In addition, in June 2011, MetLife, Inc. received $100 million from the unaffiliated financial institution related to an increase in the estimated fair value
of the surplus notes. No such payments were made or received by MetLife, Inc. during 2012 and 2010.
At December 31, 2012 and 2011, the amount of the surplus notes outstanding was $1.4 billion and $1.9 billion, respectively. At December 31,
2012 and 2011, the amount of the receivable from the unaffiliated financial institution was $182 million and $241 million, respectively.
In addition, at December 31, 2012 and 2011, MetLife, Inc. had pledged collateral with an estimated fair value of $120 million and $125 million,
respectively, to the unaffiliated financial institution.
A majority of the proceeds from the offering of the surplus notes was placed in a trust, which is consolidated by the Company, to support MRC’s
statutory obligations associated with the assumed closed block liabilities. At December 31, 2012 and 2011, the estimated fair value of assets held in
trust by the Company was $1.6 billion and $2.0 billion, respectively. The assets are principally invested in fixed maturity securities and are presented as
such within the Company’s consolidated balance sheets, with the related income included within net investment income in the Company’s consolidated
statements of operations. Interest expense on the collateral financing arrangement is included as a component of other expenses.
Interest expense related to this collateral financing arrangement was $26 million, $35 million and $36 million for the years ended December 31,
2012, 2011 and 2010, respectively.
MetLife, Inc. 167